TickerFacts.

SAB Biotherapeutics, Inc. (SABS): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2024-03-29. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

47.61M
As of 2025-12-31
83.49M
As of 2026-06-30
+111.4%
3-year compound annual growth
2020-12-31: 25.97M2021-12-31: 43.49M2022-03-31: 42.96M2022-06-30: 43.03M2022-12-31: 5.04M2023-12-31: 9.23M2024-12-31: 9.29M2025-12-31: 47.61M47.61M
2020-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3147.61M+412.5%2026-03-09, Balance as of period end
2024-12-319.29M+0.7%2026-03-09, Balance as of period end
2023-12-319.23M+83.0%2025-03-31, Balance as of period end
2022-12-315.04Mn/c2024-03-29, Balance as of period end
2022-06-3043.03Mn/a2023-04-14, Balance as of period end
2022-03-3142.96Mn/a2023-04-14, Balance as of period end
2021-12-3143.49M+67.4%2023-04-28, Balance as of period end
2020-12-3125.97Mn/a2023-04-28, Balance as of period end